Trial results investigating the benefit of a diagnostic MRI in cases of pathological nipple discharge with normal mammography/ultrasound for Breast Cancer were posted on ClinicalTrials.gov on 2025-10-15. The study enrolled 70 participants.
Background
Breast cancer is a significant global health concern, and early detection is crucial for improving patient outcomes. Pathological nipple discharge can be a symptom of underlying breast conditions, including breast cancer. When initial imaging methods like mammography and ultrasound appear normal despite pathological nipple discharge, further diagnostic tools are often considered to rule out malignancy. Magnetic Resonance Imaging (MRI) is a highly sensitive imaging technique that can provide detailed views of breast tissue, potentially identifying lesions not visible with other modalities. Investigating the utility of MRI in such specific scenarios aims to refine diagnostic pathways and ensure comprehensive evaluation for patients at risk.
Trial design
This completed study, titled "Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound", enrolled 70 participants. The trial aimed to assess the diagnostic benefit of MRI in patients presenting with pathological nipple discharge when conventional mammography and ultrasound findings were normal. The condition studied was Breast Cancer.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for study NCT02819362 were posted on 2025-10-15 on clinicaltrials.gov.